TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Community
Main Feed
Today's Market Intel
Top Stocks
AI-Curated Stock Lists
IPO Calendar
Upcoming Listings
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
Stock Reports
AI Research Reports
Commentary
Opinionated Stock Takes
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Account
Plan, Billing & Appearance
Log inCreate Account
← All Stock Lists
▌Top Stocks · HEALTHCARE REITS·Updated November 11, 2026

Healthcare REITs Stocks to Own in November 2026: 7 Names

A seven-stock countdown spans senior housing, medical office, skilled nursing and diversified healthcare real estate, from smaller specialists to larger operators.

Top Stocks · HEALTHCARE REITSUpdated November 11, 2026
CHCTDHCSBRANHIAHR+2 locked
Last refreshed November 11, 2026·14 min read
Healthcare REITs Stocks to Own in November 2026: 7 Names

Healthcare REITs remain one of the clearest demographic-driven themes in real estate. Aging baby boomers, rising care needs and improving operating conditions are supporting demand for senior housing, medical facilities and other healthcare properties, even as investors continue to navigate an uneven macroeconomic backdrop. The sector’s market performance has reflected that resilience: Nareit reported on September 2, 2026, that healthcare REITs had gained 23.1% through the end of August. That result suggests the recovery is no longer only a long-term demographic story; it is also becoming an earnings and valuation story.

The investment case rests on several structural supports, including limited new supply in some markets, improving occupancy, established operator relationships and generally conservative balance sheets. The main sub-segments are senior housing operating portfolios, senior housing triple-net leases, medical office buildings, skilled nursing facilities, life science assets and hospitals. Senior housing is currently the biggest swing factor because it captures the strongest demand tailwind, while medical office tends to provide steadier exposure. Skilled nursing offers more operating leverage, and life science remains more cyclical and sensitive to funding conditions.

This countdown moves from number seven to number one, combining focused healthcare landlords with diversified platforms that span multiple property types. The ordering gives priority to depth of exposure to the healthcare REIT theme and then considers business fundamentals, including growth, profitability, valuation, earnings execution and the current analyst view. That framework favors companies with direct participation in the sector’s strongest demand pools, while still recognizing the risks created by elevated valuations, weak earnings or operator concentration.

The screen uses a universe of U.S.-listed healthcare REITs with market capitalizations above $500 million. Stocks are ranked first by the depth and relevance of their healthcare real estate exposure, then by fundamentals such as revenue and earnings growth, margins, valuation, balance-sheet signals, earnings history and analyst consensus. The composite quality grade is included as a compact cross-check rather than the sole decision factor. This is a countdown: the analysis begins with number seven and reserves the number-one selection for the end.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

7. CHCT — Community Healthcare Trust Inc

Market cap: $0.4B · Quality grade: B · Analyst consensus: Hold (avg target $17)

What they do. The company owns income-producing real estate associated primarily with outpatient healthcare services in targeted U.S. sub-markets. As of June 30, 2026, its portfolio included approximately 197 properties, 4.5 million square feet and investments of approximately $1.2 billion across 36 states. That focused outpatient strategy gives CHCT a specialized position, although its smaller scale makes execution and financing discipline particularly important.

Why it fits. CHCT offers direct exposure to medical office and outpatient healthcare real estate, one of the steadier sub-segments within the theme. Its properties are tied to the delivery of outpatient services rather than relying primarily on a single senior housing operating model, giving investors a more specialized medical-facilities angle. The 197-property footprint also provides geographic diversification across 36 states.

Numbers that matter. Revenue grew 4.4% year over year, while earnings growth was 179.9%, though the latter figure reflects a comparatively volatile earnings base. The company reported an 80.8% gross margin, a 35.78% operating margin and a 17.76% net margin, with return on equity at 5.33% and return on assets at 2.23%. The trailing P/E was 20.3 and the forward P/E was 37.3, so the valuation does not present an obvious discount despite the modest revenue growth.

Recent momentum. CHCT beat the estimate in the November 3, 2026 quarter, reporting EPS of $0.58 versus an estimate of $0.47 for a 23.4% surprise. It also beat by 19.1% in the prior quarter, although its eight-quarter record stands at 4 beats out of 8. The analyst panel includes one Buy and two Holds, with a consensus score of 3.75 and an average target of $17, supporting a balanced rather than aggressive outlook.

6. DHC — Diversified Healthcare Trust

Market cap: $1.8B · Quality grade: C- · Analyst consensus: Hold (avg target $9.88)

What they do. The company owns a diversified U.S. healthcare property portfolio spanning senior housing, medical office and life science assets. As of September 30, 2026, that portfolio totaled approximately $6.3 billion across 285 properties in 33 states and Washington, D.C., including 23,773 senior living units and approximately 5.6 million square feet of medical office and life science space. The mix gives DHC broad healthcare exposure, while its management by The RMR Group adds an established real estate operating platform.

Why it fits. DHC covers several of the theme’s key sub-segments in one vehicle. Senior living provides exposure to the aging-population demand tailwind, medical office adds a comparatively stable outpatient component, and life science assets provide participation in a more cyclical healthcare property category. That breadth makes DHC a thematic fit, but the combination also creates more varied operating and capital-market risks than a focused medical-office landlord.

Numbers that matter. Revenue declined 5.4% year over year, earnings growth was negative 68.4%, and trailing EPS was negative $0.63; next-year EPS is estimated at negative $0.44. Profitability is the central weakness, with a negative 10.29% net margin, negative 0.23% return on assets and negative 9.45% return on equity. The trailing P/E is unavailable because earnings are negative, while the forward P/E is 16.6, a valuation that depends on the expected improvement in losses becoming reality.

Recent momentum. The latest quarter, reported November 2, 2026, produced EPS of $0.13 versus an estimate of $0.15, a 13.3% miss. DHC had beaten estimates in the previous six quarters, including a 14.3% beat in August, and its eight-quarter record is 7 beats out of 8. The analyst breakdown shows one Buy and two Holds, with a consensus score of 4 and an average target of $9.875, but the operating losses remain the more important issue.

5. SBRA — Sabra Healthcare REIT Inc

Market cap: $5.6B · Quality grade: B · Analyst consensus: Hold (avg target $22.50)

What they do. The company is a self-administered, self-managed REIT that owns and invests in real estate serving the healthcare industry across the United States and Canada. Its platform is focused on healthcare facilities and generates property-based income from assets serving care providers. The self-managed structure gives Sabra direct control over its investment and operating decisions, while its geographic footprint provides exposure to multiple healthcare markets.

Why it fits. Sabra is a direct healthcare real estate vehicle rather than a diversified generalist landlord. Its assets serve the healthcare industry across two countries, giving investors concentrated participation in the sector’s demand for care facilities. That exposure is particularly relevant as occupancy and operator economics recover, although the business remains tied to the financial health of healthcare tenants and operators.

Numbers that matter. Revenue grew 31.6% year over year and earnings grew 22.2%, while next-year EPS is estimated at $0.725 versus trailing EPS of $0.27. The company reported a 49.6% gross margin, a 26.25% operating margin and a 7.74% net margin; return on equity was 2.52% and return on assets was 1.93%. Valuation remains demanding on reported earnings, with a trailing P/E of 79.0 and a forward P/E of 32.2.

Recent momentum. Sabra beat the November 2, 2026 EPS estimate by 5.1%, reporting $0.41 against $0.39, after a 5.3% beat in August. Its eight-quarter record is 4 beats out of 8, so the latest improvement has not yet produced a consistently strong surprise pattern. The consensus breakdown is one Buy and ten Holds, with a score of 3.6875 and an average target of $22.50, signaling measured confidence rather than broad conviction.

Get AI research on any stock

Instant reports, daily intelligence, and an AI analyst in your pocket.

Get Started →

4. NHI — National Health Investors Inc

Market cap: $3.3B · Quality grade: A+ · Analyst consensus: Hold (avg target $78.50)

What they do. National Health Investors is a self-managed REIT that owns, leases, operates and finances healthcare real estate in the United States. Its portfolio includes independent living, assisted living, entrance-fee communities, senior living campuses, skilled nursing facilities and hospitals, and the company reports through Real Estate Investments and SHOP segments. This combination gives NHI both property-based exposure and participation in senior housing operations.

Why it fits. NHI is closely aligned with the sector’s strongest demographic drivers because senior housing is central to its portfolio. Its exposure also extends to skilled nursing, hospitals and medical facilities, creating a broad healthcare real estate mix without losing the senior-care focus. That balance makes it relevant to both the occupancy recovery in senior housing and the more operationally leveraged skilled nursing segment.

Numbers that matter. Revenue grew 26.2% year over year and reported earnings growth was 1,562.3%, a very large comparison that investors should not automatically treat as a normalized run rate. Trailing EPS was $3.46, next-year EPS is estimated at $3.45, and the trailing and forward P/E ratios were 19.6 and 18.1, respectively. The company reported a 68.8% gross margin, a 26.23% operating margin, return on equity of 38.61% and return on assets of 3.88%; the reported net margin was 151.84%.

Recent momentum. NHI missed the November 9, 2026 estimate by 4.3%, with EPS of $1.12 versus $1.17, and also missed by 5.6% in August. The company still has a 4-of-8 beat rate, but the four most recent quarters were all misses. The analyst panel contains three Holds and no listed Buy or Sell votes, with a consensus score of 4.25 and an average target of $78.50, leaving the strong composite grade balanced against recent execution softness.

3. AHR — American Healthcare REIT, Inc.

Market cap: $13.8B · Quality grade: B- · Analyst consensus: Buy (avg target $64.75)

What they do. American Healthcare REIT owns and operates clinical healthcare real estate across the United States, the United Kingdom and the Isle of Man. Its portfolio includes senior housing, skilled nursing facilities, outpatient medical buildings and other healthcare-related properties, with senior housing operated under the RIDEA structure. The company also originates and acquires secured loans and uses an integrated management platform to operate its real estate businesses.

Why it fits. AHR provides unusually deep exposure to the healthcare continuum, combining senior housing’s demographic upside with skilled nursing and outpatient medical properties. The RIDEA operating model gives the company more direct participation in senior housing performance than a purely triple-net landlord, which can increase upside when occupancy and operating results improve. At the same time, its outpatient medical platform offers exposure to a steadier healthcare real estate category.

Numbers that matter. Revenue grew 29.4% year over year, but earnings growth declined 57.6%, highlighting the difference between portfolio expansion and bottom-line momentum. Trailing EPS was $0.49 and next-year EPS is estimated at $0.99, while the reported net margin was 3.6%, operating margin was 7.06% and return on equity was 2.33%. Valuation is elevated at 121.2 times trailing earnings and 48.1 times forward earnings, placing substantial importance on the expected earnings improvement.

Recent momentum. AHR beat the November 5, 2026 estimate by 3.6%, with EPS of $0.58 versus $0.56, and followed that with a 3.8% beat in August. Its eight-quarter record is 5 beats out of 8, showing improving recent execution but not a perfect record. Analysts are more constructive than the composite grade, with six Buys, no listed Holds or Sells, a consensus score of 4.625 and an average target of $64.75.

Pick #2Premium members only

Premium members see this pick's full breakdown — investment thesis, key financial metrics, recent earnings execution, and analyst consensus.

Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.

Get Full Access →
Pick #1Premium members only

Premium members see this pick's full breakdown — investment thesis, key financial metrics, recent earnings execution, and analyst consensus.

Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.

Get Full Access →

Methodology

The screen covers U.S.-listed healthcare REITs with a market capitalization above $500 million and uses primary-source company descriptions, financial metrics, earnings history and analyst consensus data. Ranking is based first on depth of exposure to healthcare real estate, with additional consideration given to revenue and earnings growth, profitability, valuation, balance-sheet indicators, earnings surprises and the composite quality grade. The results are presented as a countdown from number seven to number one, rather than as a simple valuation ranking. The article is refreshed monthly so that company fundamentals, consensus data and the relative positioning of the candidates can be reassessed as the sector develops.

▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

Creates a free TickerSpark account — newsletter included.

or with email

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌For Active Investors

Don't trade alone.

Get market intelligence delivered daily.

Get Full Access →

Not ready to subscribe? ·

▌For Active Investors

Stock research for every investor

  • Reports on any stock
  • Daily market intelligence
  • AI analyst in your pocket
  • Portfolio analysis tools
Get Full Access →

Cancel anytime

▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, free in your inbox.

Creates a free TickerSpark account — newsletter included.

or with email

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌More stock lists

More to read

All articles
7 Zero Trust Security Stocks Worth Watching in November 2026

7 Zero Trust Security Stocks Worth Watching in November 2026

This countdown spans identity, SASE, endpoint, cloud and network-security businesses across the zero trust security landscape.

Nov 18·13 min
Top Healthcare Dividend Stocks: Our 5 Picks for November 2026

Top Healthcare Dividend Stocks: Our 5 Picks for November 2026

Healthcare dividend stocks span insurers, distributors, diagnostics, medical devices, and branded medicines in this five-stock November 2026 countdown.

Nov 18·11 min
Independent Power Producers Stocks to Own in 2026: 5 Names

Independent Power Producers Stocks to Own in 2026: 5 Names

A five-stock countdown spans merchant, nuclear, renewable, coal, gas and hybrid power platforms, with Hallador, Brookfield and Talen offering distinct exposures.

Nov 3·10 min